Skip to main content

Tourette's Syndrome

3
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
3
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Emalex Biosciences
Emalex BiosciencesIL - Chicago
1 program
1
EcopipamPhase 21 trial
Active Trials
NCT02102698Completed40Est. Dec 2019
Pfizer
PfizerNEW YORK, NY
1 program
1
PF-03654746Phase 21 trial
Active Trials
NCT01475383Withdrawn0Est. Apr 2012
Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
1 program
1
Tetrabenazine MRPhase 21 trial
Active Trials
NCT01133353Withdrawn0Est. Dec 2011
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Comprehensive Behavioral Intervention for TicsN/A1 trial
Active Trials
NCT03042507Completed15Est. Feb 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Emalex BiosciencesEcopipam
PfizerPF-03654746
Bausch HealthTetrabenazine MR
Angeles TherapeuticsComprehensive Behavioral Intervention for Tics

Clinical Trials (4)

Total enrollment: 55 patients across 4 trials

NCT02102698Emalex BiosciencesEcopipam

Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years

Start: Mar 2014Est. completion: Dec 201940 patients
Phase 2Completed
NCT01475383PfizerPF-03654746

Study Evaluating The Safety And Efficacy Of PF-03654746 In Adult Subjects With Tourette's Syndrome

Start: Apr 2012Est. completion: Apr 20120
Phase 2Withdrawn
NCT01133353Bausch HealthTetrabenazine MR

A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome

Start: Mar 2011Est. completion: Dec 20110
Phase 2Withdrawn
NCT03042507Angeles TherapeuticsComprehensive Behavioral Intervention for Tics

Psychosocial Intervention for Young Children With Chronic Tics

Start: Jan 2012Est. completion: Feb 201315 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.